COCRYSTAL PHARMA, INC. Selling Expense
COCRYSTAL PHARMA, INC. (COCP) reported Selling Expense of $221.56 thousand for the 3-month period ending 2012-03-31, per its 10-Q/A filed 2012-10-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2012-10-02
- COCRYSTAL PHARMA, INC. selling expense for the quarter ending 2012-03-31 was $221.56K, a 60.45% increase year-over-year.
- COCRYSTAL PHARMA, INC. selling expense for the quarter ending 2011-03-31 was $138.09K.
| Period end | Selling Expense 3 month |
|---|---|
| 2012-03-31 | $221.56K 10-Q/A · filed 2012-10-02 |
| 2011-03-31 | $138.09K 10-Q/A · filed 2012-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |